Akebia Therapeutics Inc. (AKBA) gained 12.79% or 0.83 to $7.32. It is approximately 1.53 million shares traded, which is 213.79% compare to the average total volume 716707. The market cap of AKBA is $855.62 million. The year to date change is 24.69%. The 52 week price range is from $5.2 to $15.37. Price of AKBA have changed 0.31% during last week. It have changed 7.81% over last month, -10.97% over last 3 months, -16.90% over last 6 months and -52.35% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 6.39. It is -12.70% below current price. The 200-day Moving Averages for AKBA is 8.39. It is 14.62% above current price. The 52-week High is 15.37. It is 109.97% from the current price. The 52-week Low is 5.2. It is -28.96% from current price.
There are some statistics of AKBA. It is has market cap $855.62 million. The share outstanding is 116.89 million. The average volume is 716707. The percent of top 15 Institution holding is 56.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -59.04%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -19.29%.